Insuline Pen NaaldenAlso known as: Insulin Pen Needles, Insulin Needle 4mm

Mechanism of Action

Not applicable. These are sterile insulin pen needles designed to deliver precise subcutaneous injections of peptides or insulin by enabling controlled dosage administration into subcutaneous tissue.

Reported Research Benefits

Used primarily for accurate subcutaneous delivery of peptides such as BPC-157 in laboratory or research settings; compatible with refillable insulin pens for precise dosing.

Dosing Protocol & Reconstitution

This product is a delivery device (needle) and does not itself have dosing. Typically employed with insulin pens loaded with research peptides for controlled dosing protocols.

Research Notes

The 4 mm length minimizes tissue damage and pain, allowing precise subcutaneous administration in experimental peptide research. Not for human use or clinical treatment.

Research Summary

Insulin pen needles, such as the Insuline Pen Naalden, are medical devices designed to facilitate the subcutaneous injection of insulin for diabetes management. Research primarily focuses on needle length and gauge optimization to improve patient comfort, reduce injection pain, and enhance insulin delivery precision. High-quality clinical trials have demonstrated that shorter needles (e.g., 4mm) are effective across diverse patient populations, reducing skin trauma without compromising insulin absorption. However, studies note variability in individual patient preferences and technique, emphasizing the need for proper education on needle usage to maximize benefits.

Side Effects & Safety

The primary safety considerations with insulin pen needles involve local site reactions such as pain, redness, bruising, or lipodystrophy with repeated injections in the same area. These devices themselves do not have systemic side effects since they are inactive and sterile, but improper use can lead to infections or dosing errors. Animal studies are not applicable given the device nature of the product. There are no known drug interactions with the needles themselves, though careful management of insulin dosing and injection site rotation is critical. These needles are sterile single-use devices and are not subject to WADA regulations as they are tools rather than pharmacological agents.

Stability & Storage

Refer to research notes

Molecular Data

Primary literature: https://pubmed.ncbi.nlm.nih.gov/?term=Insulin+Pen+Needles